查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1867544

适体：全球市场占有率和排名、总收入和需求预测（2025-2031年）

Aptamers - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
出版日期: | 出版商: QYResearch | 英文 118 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

全球适体市场预计在 2024 年达到 4.13 亿美元，预计到 2031 年将达到 11.78 亿美元，2025 年至 2031 年的复合年增长率为 15.7%。

适体是源自RNA或DNA的高亲和性分子。它们通常透过一种称为「配体指数富集系统演化」（SELEX）的合成方法产生。适体的名称源自于拉丁语“aptus”，意为“匹配”，指的是以高特异性和亲和性与目标分子结合。适体是能够以高亲和性和特异性与多种标靶相互作用的短链核酸。研究表明，适体能够抑制其相应目标蛋白的生物学功能，并且可以透过体外筛选方法（也称为SELEX，即配体指数富集系统进化）进行鑑定。作为核酸，适体可以透过化学或酶方法合成。

随着mRNA疫苗和siRNA药物逐渐走向临床成熟，作为核酸治疗平台关键组成部分的适体因其在标靶治疗、细胞识别和精准递送方面的优势而备受关注。生物製药公司、合成生物学创新者和领先的体外诊断（IVD）公司正将适体技术纳入其策略性研发管线，以拓展其在肿瘤学、眼科学、自体免疫疾病和病毒感染疾病等广泛领域的应用。政府对核酸药物和精准分子诊断的倡议和投资也为适体研发提供了有利的政策和资金支持。

儘管适体产业潜力巨大，但其商业化仍处于早期阶段。该产业面临许多挑战，例如靶点筛检效率低下、体内稳定性有限、缺乏行业标准以及强大的专利障碍。传统抗体供应商在资源和市场进入的主导地位也限制了适体在临床领域的应用。此外，许多地区针对适体产品的法规结构仍在不断改进，导致临床试验结果和市场准入要求存在不确定性。

下游需求正迅速从基础研究转向临床诊断和治疗。适体正成为癌症液体切片检查、神经退化性疾病早期筛检和标靶药物递送系统等高成长领域中极具商业性前景的工具。合成生物学平台公司、客製化核酸服务供应商和合约研发生产机构（CDMO）也在将适体整合到其服务中，拓展其应用领域，并强化其在整个价值链中的作用。

本报告旨在对全球适体市场进行全面分析，重点关注总收入、市场份额和主要企业的排名，并按地区/国家、类型和应用对适体进行分析。

适体市场规模、估计值和预测均以销售收入为指标，以 2024 年为基准年，并包含 2020 年至 2031 年的历史资料和预测资料。我们运用定量和定性分析，帮助读者制定适体业务和成长策略，评估市场竞争，分析自身在当前市场中的地位，并做出明智的商业决策。

市场区隔

公司

  • TriLink BioTechnologies
  • AptaBharat
  • SomaLogic
  • AM Biotechnologies
  • Aptamer Sciences
  • Base Pair Biotechnologies
  • Aptamer Group
  • Aptagen
  • Aptus Biotech
  • NeoVentures Biotechnology
  • Ray Biotech
  • Vivonics

按类型分類的细分市场

  • 基于DNA的适体
  • 基于RNA的适体

应用领域

  • 研究与开发
  • 药物发现

按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太地区
    • 中国
    • 日本
    • 韩国
    • 东南亚
    • 印度
    • 澳洲
    • 亚太其他地区
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 荷兰
    • 北欧国家
    • 其他欧洲
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 其他拉丁美洲
  • 中东和非洲
    • 土耳其
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 其他中东和非洲地区

The global market for Aptamers was estimated to be worth US$ 413 million in 2024 and is forecast to a readjusted size of US$ 1178 million by 2031 with a CAGR of 15.7% during the forecast period 2025-2031.

Aptamers are high affinity molecules that are derived from RNA or DNA. These are normally generated using a synthetic process called "Systematic evolution of ligands by exponential enrichment" (SELEX). Aptamers receive their name from the Latin word aptus meaning "fit". This means they bind to the target molecules with high specificity and high affinity. Aptamers are short nucleic acids that interact with a variety of targets with high affinity and specificity. They have been shown to inhibit biological functions of cognate target proteins, and they are identifiable by an in vitro selection process, also termed SELEX (Systematic Evolution of Ligands by EXponential enrichment). Being nucleic acids, aptamers can be synthesized chemically or enzymatically.

As mRNA vaccines and siRNA drugs gain clinical maturity, aptamers-an essential part of the nucleic acid therapeutic platform-are drawing attention for their advantages in targeted therapy, cell recognition, and precision delivery. Biopharmaceutical companies, synthetic biology innovators, and leading IVD players are incorporating aptamer technologies into their strategic pipelines, expanding applications across oncology, ophthalmology, autoimmune diseases, and viral infections. Government initiatives and investment support for nucleic acid drugs and precision molecular diagnostics further provide favorable policies and financial backing for aptamer development.

Despite the high potential, the aptamer industry remains at an early commercialization stage. It faces challenges such as inefficient target screening, limited in vivo stability, lack of industrial standards, and strong patent barriers. Dominance by traditional antibody suppliers in resources and market access also constrains aptamer adoption in clinical settings. Moreover, regulatory frameworks for aptamer-based products are still evolving in many regions, posing uncertainties in clinical trial outcomes and market entry requirements.

Downstream demand is rapidly shifting from basic research to clinical diagnostics and therapeutics. In high-growth segments such as liquid biopsy for cancer, early screening for neurodegenerative disorders, and targeted drug delivery systems, aptamers are emerging as commercially promising tools. Synthetic biology platform companies, custom nucleic acid service providers, and CDMOs are also integrating aptamers into their offerings, expanding the application landscape and reinforcing their role across the value chain.

This report aims to provide a comprehensive presentation of the global market for Aptamers, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Aptamers by region & country, by Type, and by Application.

The Aptamers market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Aptamers.

Market Segmentation

By Company

  • TriLink BioTechnologies
  • AptaBharat
  • SomaLogic
  • AM Biotechnologies
  • Aptamer Sciences
  • Base Pair Biotechnologies
  • Aptamer Group
  • Aptagen
  • Aptus Biotech
  • NeoVentures Biotechnology
  • Ray Biotech
  • Vivonics

Segment by Type

  • DNA-Based Aptamers
  • RNA-Based Aptamers

Segment by Application

  • Research and Development
  • Drug Discovery

By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Aptamers company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Revenue of Aptamers in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Revenue of Aptamers in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

  • 1.1 Aptamers Product Introduction
  • 1.2 Global Aptamers Market Size Forecast (2020-2031)
  • 1.3 Aptamers Market Trends & Drivers
    • 1.3.1 Aptamers Industry Trends
    • 1.3.2 Aptamers Market Drivers & Opportunity
    • 1.3.3 Aptamers Market Challenges
    • 1.3.4 Aptamers Market Restraints
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Competitive Analysis by Company

  • 2.1 Global Aptamers Players Revenue Ranking (2024)
  • 2.2 Global Aptamers Revenue by Company (2020-2025)
  • 2.3 Key Companies Aptamers Manufacturing Base Distribution and Headquarters
  • 2.4 Key Companies Aptamers Product Offered
  • 2.5 Key Companies Time to Begin Mass Production of Aptamers
  • 2.6 Aptamers Market Competitive Analysis
    • 2.6.1 Aptamers Market Concentration Rate (2020-2025)
    • 2.6.2 Global 5 and 10 Largest Companies by Aptamers Revenue in 2024
    • 2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Aptamers as of 2024)
  • 2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

  • 3.1 Introduction by Type
    • 3.1.1 DNA-Based Aptamers
    • 3.1.2 RNA-Based Aptamers
  • 3.2 Global Aptamers Sales Value by Type
    • 3.2.1 Global Aptamers Sales Value by Type (2020 VS 2024 VS 2031)
    • 3.2.2 Global Aptamers Sales Value, by Type (2020-2031)
    • 3.2.3 Global Aptamers Sales Value, by Type (%) (2020-2031)

4 Segmentation by Application

  • 4.1 Introduction by Application
    • 4.1.1 Research and Development
    • 4.1.2 Drug Discovery
  • 4.2 Global Aptamers Sales Value by Application
    • 4.2.1 Global Aptamers Sales Value by Application (2020 VS 2024 VS 2031)
    • 4.2.2 Global Aptamers Sales Value, by Application (2020-2031)
    • 4.2.3 Global Aptamers Sales Value, by Application (%) (2020-2031)

5 Segmentation by Region

  • 5.1 Global Aptamers Sales Value by Region
    • 5.1.1 Global Aptamers Sales Value by Region: 2020 VS 2024 VS 2031
    • 5.1.2 Global Aptamers Sales Value by Region (2020-2025)
    • 5.1.3 Global Aptamers Sales Value by Region (2026-2031)
    • 5.1.4 Global Aptamers Sales Value by Region (%), (2020-2031)
  • 5.2 North America
    • 5.2.1 North America Aptamers Sales Value, 2020-2031
    • 5.2.2 North America Aptamers Sales Value by Country (%), 2024 VS 2031
  • 5.3 Europe
    • 5.3.1 Europe Aptamers Sales Value, 2020-2031
    • 5.3.2 Europe Aptamers Sales Value by Country (%), 2024 VS 2031
  • 5.4 Asia Pacific
    • 5.4.1 Asia Pacific Aptamers Sales Value, 2020-2031
    • 5.4.2 Asia Pacific Aptamers Sales Value by Region (%), 2024 VS 2031
  • 5.5 South America
    • 5.5.1 South America Aptamers Sales Value, 2020-2031
    • 5.5.2 South America Aptamers Sales Value by Country (%), 2024 VS 2031
  • 5.6 Middle East & Africa
    • 5.6.1 Middle East & Africa Aptamers Sales Value, 2020-2031
    • 5.6.2 Middle East & Africa Aptamers Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

  • 6.1 Key Countries/Regions Aptamers Sales Value Growth Trends, 2020 VS 2024 VS 2031
  • 6.2 Key Countries/Regions Aptamers Sales Value, 2020-2031
  • 6.3 United States
    • 6.3.1 United States Aptamers Sales Value, 2020-2031
    • 6.3.2 United States Aptamers Sales Value by Type (%), 2024 VS 2031
    • 6.3.3 United States Aptamers Sales Value by Application, 2024 VS 2031
  • 6.4 Europe
    • 6.4.1 Europe Aptamers Sales Value, 2020-2031
    • 6.4.2 Europe Aptamers Sales Value by Type (%), 2024 VS 2031
    • 6.4.3 Europe Aptamers Sales Value by Application, 2024 VS 2031
  • 6.5 China
    • 6.5.1 China Aptamers Sales Value, 2020-2031
    • 6.5.2 China Aptamers Sales Value by Type (%), 2024 VS 2031
    • 6.5.3 China Aptamers Sales Value by Application, 2024 VS 2031
  • 6.6 Japan
    • 6.6.1 Japan Aptamers Sales Value, 2020-2031
    • 6.6.2 Japan Aptamers Sales Value by Type (%), 2024 VS 2031
    • 6.6.3 Japan Aptamers Sales Value by Application, 2024 VS 2031
  • 6.7 South Korea
    • 6.7.1 South Korea Aptamers Sales Value, 2020-2031
    • 6.7.2 South Korea Aptamers Sales Value by Type (%), 2024 VS 2031
    • 6.7.3 South Korea Aptamers Sales Value by Application, 2024 VS 2031
  • 6.8 Southeast Asia
    • 6.8.1 Southeast Asia Aptamers Sales Value, 2020-2031
    • 6.8.2 Southeast Asia Aptamers Sales Value by Type (%), 2024 VS 2031
    • 6.8.3 Southeast Asia Aptamers Sales Value by Application, 2024 VS 2031
  • 6.9 India
    • 6.9.1 India Aptamers Sales Value, 2020-2031
    • 6.9.2 India Aptamers Sales Value by Type (%), 2024 VS 2031
    • 6.9.3 India Aptamers Sales Value by Application, 2024 VS 2031

7 Company Profiles

  • 7.1 TriLink BioTechnologies
    • 7.1.1 TriLink BioTechnologies Profile
    • 7.1.2 TriLink BioTechnologies Main Business
    • 7.1.3 TriLink BioTechnologies Aptamers Products, Services and Solutions
    • 7.1.4 TriLink BioTechnologies Aptamers Revenue (US$ Million) & (2020-2025)
    • 7.1.5 TriLink BioTechnologies Recent Developments
  • 7.2 AptaBharat
    • 7.2.1 AptaBharat Profile
    • 7.2.2 AptaBharat Main Business
    • 7.2.3 AptaBharat Aptamers Products, Services and Solutions
    • 7.2.4 AptaBharat Aptamers Revenue (US$ Million) & (2020-2025)
    • 7.2.5 AptaBharat Recent Developments
  • 7.3 SomaLogic
    • 7.3.1 SomaLogic Profile
    • 7.3.2 SomaLogic Main Business
    • 7.3.3 SomaLogic Aptamers Products, Services and Solutions
    • 7.3.4 SomaLogic Aptamers Revenue (US$ Million) & (2020-2025)
    • 7.3.5 SomaLogic Recent Developments
  • 7.4 AM Biotechnologies
    • 7.4.1 AM Biotechnologies Profile
    • 7.4.2 AM Biotechnologies Main Business
    • 7.4.3 AM Biotechnologies Aptamers Products, Services and Solutions
    • 7.4.4 AM Biotechnologies Aptamers Revenue (US$ Million) & (2020-2025)
    • 7.4.5 AM Biotechnologies Recent Developments
  • 7.5 Aptamer Sciences
    • 7.5.1 Aptamer Sciences Profile
    • 7.5.2 Aptamer Sciences Main Business
    • 7.5.3 Aptamer Sciences Aptamers Products, Services and Solutions
    • 7.5.4 Aptamer Sciences Aptamers Revenue (US$ Million) & (2020-2025)
    • 7.5.5 Aptamer Sciences Recent Developments
  • 7.6 Base Pair Biotechnologies
    • 7.6.1 Base Pair Biotechnologies Profile
    • 7.6.2 Base Pair Biotechnologies Main Business
    • 7.6.3 Base Pair Biotechnologies Aptamers Products, Services and Solutions
    • 7.6.4 Base Pair Biotechnologies Aptamers Revenue (US$ Million) & (2020-2025)
    • 7.6.5 Base Pair Biotechnologies Recent Developments
  • 7.7 Aptamer Group
    • 7.7.1 Aptamer Group Profile
    • 7.7.2 Aptamer Group Main Business
    • 7.7.3 Aptamer Group Aptamers Products, Services and Solutions
    • 7.7.4 Aptamer Group Aptamers Revenue (US$ Million) & (2020-2025)
    • 7.7.5 Aptamer Group Recent Developments
  • 7.8 Aptagen
    • 7.8.1 Aptagen Profile
    • 7.8.2 Aptagen Main Business
    • 7.8.3 Aptagen Aptamers Products, Services and Solutions
    • 7.8.4 Aptagen Aptamers Revenue (US$ Million) & (2020-2025)
    • 7.8.5 Aptagen Recent Developments
  • 7.9 Aptus Biotech
    • 7.9.1 Aptus Biotech Profile
    • 7.9.2 Aptus Biotech Main Business
    • 7.9.3 Aptus Biotech Aptamers Products, Services and Solutions
    • 7.9.4 Aptus Biotech Aptamers Revenue (US$ Million) & (2020-2025)
    • 7.9.5 Aptus Biotech Recent Developments
  • 7.10 NeoVentures Biotechnology
    • 7.10.1 NeoVentures Biotechnology Profile
    • 7.10.2 NeoVentures Biotechnology Main Business
    • 7.10.3 NeoVentures Biotechnology Aptamers Products, Services and Solutions
    • 7.10.4 NeoVentures Biotechnology Aptamers Revenue (US$ Million) & (2020-2025)
    • 7.10.5 NeoVentures Biotechnology Recent Developments
  • 7.11 Ray Biotech
    • 7.11.1 Ray Biotech Profile
    • 7.11.2 Ray Biotech Main Business
    • 7.11.3 Ray Biotech Aptamers Products, Services and Solutions
    • 7.11.4 Ray Biotech Aptamers Revenue (US$ Million) & (2020-2025)
    • 7.11.5 Ray Biotech Recent Developments
  • 7.12 Vivonics
    • 7.12.1 Vivonics Profile
    • 7.12.2 Vivonics Main Business
    • 7.12.3 Vivonics Aptamers Products, Services and Solutions
    • 7.12.4 Vivonics Aptamers Revenue (US$ Million) & (2020-2025)
    • 7.12.5 Vivonics Recent Developments

8 Industry Chain Analysis

  • 8.1 Aptamers Industrial Chain
  • 8.2 Aptamers Upstream Analysis
    • 8.2.1 Key Raw Materials
    • 8.2.2 Raw Materials Key Suppliers
    • 8.2.3 Manufacturing Cost Structure
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis (Customers Analysis)
  • 8.5 Sales Model and Sales Channels
    • 8.5.1 Aptamers Sales Model
    • 8.5.2 Sales Channel
    • 8.5.3 Aptamers Distributors

9 Research Findings and Conclusion

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Methodology/Research Approach
      • 10.1.1.1 Research Programs/Design
      • 10.1.1.2 Market Size Estimation
      • 10.1.1.3 Market Breakdown and Data Triangulation
    • 10.1.2 Data Source
      • 10.1.2.1 Secondary Sources
      • 10.1.2.2 Primary Sources
  • 10.2 Author Details
  • 10.3 Disclaimer

List of Tables

  • Table 1. Aptamers Market Trends
  • Table 2. Aptamers Market Drivers & Opportunity
  • Table 3. Aptamers Market Challenges
  • Table 4. Aptamers Market Restraints
  • Table 5. Global Aptamers Revenue by Company (2020-2025) & (US$ Million)
  • Table 6. Global Aptamers Revenue Market Share by Company (2020-2025)
  • Table 7. Key Companies Aptamers Manufacturing Base Distribution and Headquarters
  • Table 8. Key Companies Aptamers Product Type
  • Table 9. Key Companies Time to Begin Mass Production of Aptamers
  • Table 10. Global Aptamers Companies Market Concentration Ratio (CR5 and HHI)
  • Table 11. Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Aptamers as of 2024)
  • Table 12. Mergers & Acquisitions, Expansion Plans
  • Table 13. Global Aptamers Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 14. Global Aptamers Sales Value by Type (2020-2025) & (US$ Million)
  • Table 15. Global Aptamers Sales Value by Type (2026-2031) & (US$ Million)
  • Table 16. Global Aptamers Sales Market Share in Value by Type (2020-2025)
  • Table 17. Global Aptamers Sales Market Share in Value by Type (2026-2031)
  • Table 18. Global Aptamers Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 19. Global Aptamers Sales Value by Application (2020-2025) & (US$ Million)
  • Table 20. Global Aptamers Sales Value by Application (2026-2031) & (US$ Million)
  • Table 21. Global Aptamers Sales Market Share in Value by Application (2020-2025)
  • Table 22. Global Aptamers Sales Market Share in Value by Application (2026-2031)
  • Table 23. Global Aptamers Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
  • Table 24. Global Aptamers Sales Value by Region (2020-2025) & (US$ Million)
  • Table 25. Global Aptamers Sales Value by Region (2026-2031) & (US$ Million)
  • Table 26. Global Aptamers Sales Value by Region (2020-2025) & (%)
  • Table 27. Global Aptamers Sales Value by Region (2026-2031) & (%)
  • Table 28. Key Countries/Regions Aptamers Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
  • Table 29. Key Countries/Regions Aptamers Sales Value, (2020-2025) & (US$ Million)
  • Table 30. Key Countries/Regions Aptamers Sales Value, (2026-2031) & (US$ Million)
  • Table 31. TriLink BioTechnologies Basic Information List
  • Table 32. TriLink BioTechnologies Description and Business Overview
  • Table 33. TriLink BioTechnologies Aptamers Products, Services and Solutions
  • Table 34. Revenue (US$ Million) in Aptamers Business of TriLink BioTechnologies (2020-2025)
  • Table 35. TriLink BioTechnologies Recent Developments
  • Table 36. AptaBharat Basic Information List
  • Table 37. AptaBharat Description and Business Overview
  • Table 38. AptaBharat Aptamers Products, Services and Solutions
  • Table 39. Revenue (US$ Million) in Aptamers Business of AptaBharat (2020-2025)
  • Table 40. AptaBharat Recent Developments
  • Table 41. SomaLogic Basic Information List
  • Table 42. SomaLogic Description and Business Overview
  • Table 43. SomaLogic Aptamers Products, Services and Solutions
  • Table 44. Revenue (US$ Million) in Aptamers Business of SomaLogic (2020-2025)
  • Table 45. SomaLogic Recent Developments
  • Table 46. AM Biotechnologies Basic Information List
  • Table 47. AM Biotechnologies Description and Business Overview
  • Table 48. AM Biotechnologies Aptamers Products, Services and Solutions
  • Table 49. Revenue (US$ Million) in Aptamers Business of AM Biotechnologies (2020-2025)
  • Table 50. AM Biotechnologies Recent Developments
  • Table 51. Aptamer Sciences Basic Information List
  • Table 52. Aptamer Sciences Description and Business Overview
  • Table 53. Aptamer Sciences Aptamers Products, Services and Solutions
  • Table 54. Revenue (US$ Million) in Aptamers Business of Aptamer Sciences (2020-2025)
  • Table 55. Aptamer Sciences Recent Developments
  • Table 56. Base Pair Biotechnologies Basic Information List
  • Table 57. Base Pair Biotechnologies Description and Business Overview
  • Table 58. Base Pair Biotechnologies Aptamers Products, Services and Solutions
  • Table 59. Revenue (US$ Million) in Aptamers Business of Base Pair Biotechnologies (2020-2025)
  • Table 60. Base Pair Biotechnologies Recent Developments
  • Table 61. Aptamer Group Basic Information List
  • Table 62. Aptamer Group Description and Business Overview
  • Table 63. Aptamer Group Aptamers Products, Services and Solutions
  • Table 64. Revenue (US$ Million) in Aptamers Business of Aptamer Group (2020-2025)
  • Table 65. Aptamer Group Recent Developments
  • Table 66. Aptagen Basic Information List
  • Table 67. Aptagen Description and Business Overview
  • Table 68. Aptagen Aptamers Products, Services and Solutions
  • Table 69. Revenue (US$ Million) in Aptamers Business of Aptagen (2020-2025)
  • Table 70. Aptagen Recent Developments
  • Table 71. Aptus Biotech Basic Information List
  • Table 72. Aptus Biotech Description and Business Overview
  • Table 73. Aptus Biotech Aptamers Products, Services and Solutions
  • Table 74. Revenue (US$ Million) in Aptamers Business of Aptus Biotech (2020-2025)
  • Table 75. Aptus Biotech Recent Developments
  • Table 76. NeoVentures Biotechnology Basic Information List
  • Table 77. NeoVentures Biotechnology Description and Business Overview
  • Table 78. NeoVentures Biotechnology Aptamers Products, Services and Solutions
  • Table 79. Revenue (US$ Million) in Aptamers Business of NeoVentures Biotechnology (2020-2025)
  • Table 80. NeoVentures Biotechnology Recent Developments
  • Table 81. Ray Biotech Basic Information List
  • Table 82. Ray Biotech Description and Business Overview
  • Table 83. Ray Biotech Aptamers Products, Services and Solutions
  • Table 84. Revenue (US$ Million) in Aptamers Business of Ray Biotech (2020-2025)
  • Table 85. Ray Biotech Recent Developments
  • Table 86. Vivonics Basic Information List
  • Table 87. Vivonics Description and Business Overview
  • Table 88. Vivonics Aptamers Products, Services and Solutions
  • Table 89. Revenue (US$ Million) in Aptamers Business of Vivonics (2020-2025)
  • Table 90. Vivonics Recent Developments
  • Table 91. Key Raw Materials Lists
  • Table 92. Raw Materials Key Suppliers Lists
  • Table 93. Aptamers Downstream Customers
  • Table 94. Aptamers Distributors List
  • Table 95. Research Programs/Design for This Report
  • Table 96. Key Data Information from Secondary Sources
  • Table 97. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Aptamers Product Picture
  • Figure 2. Global Aptamers Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
  • Figure 3. Global Aptamers Sales Value (2020-2031) & (US$ Million)
  • Figure 4. Aptamers Report Years Considered
  • Figure 5. Global Aptamers Players Revenue Ranking (2024) & (US$ Million)
  • Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Aptamers Revenue in 2024
  • Figure 7. Aptamers Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
  • Figure 8. DNA-Based Aptamers Picture
  • Figure 9. RNA-Based Aptamers Picture
  • Figure 10. Global Aptamers Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 11. Global Aptamers Sales Value Market Share by Type, 2024 & 2031
  • Figure 12. Product Picture of Research and Development
  • Figure 13. Product Picture of Drug Discovery
  • Figure 14. Global Aptamers Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 15. Global Aptamers Sales Value Market Share by Application, 2024 & 2031
  • Figure 16. North America Aptamers Sales Value (2020-2031) & (US$ Million)
  • Figure 17. North America Aptamers Sales Value by Country (%), 2024 VS 2031
  • Figure 18. Europe Aptamers Sales Value, (2020-2031) & (US$ Million)
  • Figure 19. Europe Aptamers Sales Value by Country (%), 2024 VS 2031
  • Figure 20. Asia Pacific Aptamers Sales Value, (2020-2031) & (US$ Million)
  • Figure 21. Asia Pacific Aptamers Sales Value by Region (%), 2024 VS 2031
  • Figure 22. South America Aptamers Sales Value, (2020-2031) & (US$ Million)
  • Figure 23. South America Aptamers Sales Value by Country (%), 2024 VS 2031
  • Figure 24. Middle East & Africa Aptamers Sales Value, (2020-2031) & (US$ Million)
  • Figure 25. Middle East & Africa Aptamers Sales Value by Country (%), 2024 VS 2031
  • Figure 26. Key Countries/Regions Aptamers Sales Value (%), (2020-2031)
  • Figure 27. United States Aptamers Sales Value, (2020-2031) & (US$ Million)
  • Figure 28. United States Aptamers Sales Value by Type (%), 2024 VS 2031
  • Figure 29. United States Aptamers Sales Value by Application (%), 2024 VS 2031
  • Figure 30. Europe Aptamers Sales Value, (2020-2031) & (US$ Million)
  • Figure 31. Europe Aptamers Sales Value by Type (%), 2024 VS 2031
  • Figure 32. Europe Aptamers Sales Value by Application (%), 2024 VS 2031
  • Figure 33. China Aptamers Sales Value, (2020-2031) & (US$ Million)
  • Figure 34. China Aptamers Sales Value by Type (%), 2024 VS 2031
  • Figure 35. China Aptamers Sales Value by Application (%), 2024 VS 2031
  • Figure 36. Japan Aptamers Sales Value, (2020-2031) & (US$ Million)
  • Figure 37. Japan Aptamers Sales Value by Type (%), 2024 VS 2031
  • Figure 38. Japan Aptamers Sales Value by Application (%), 2024 VS 2031
  • Figure 39. South Korea Aptamers Sales Value, (2020-2031) & (US$ Million)
  • Figure 40. South Korea Aptamers Sales Value by Type (%), 2024 VS 2031
  • Figure 41. South Korea Aptamers Sales Value by Application (%), 2024 VS 2031
  • Figure 42. Southeast Asia Aptamers Sales Value, (2020-2031) & (US$ Million)
  • Figure 43. Southeast Asia Aptamers Sales Value by Type (%), 2024 VS 2031
  • Figure 44. Southeast Asia Aptamers Sales Value by Application (%), 2024 VS 2031
  • Figure 45. India Aptamers Sales Value, (2020-2031) & (US$ Million)
  • Figure 46. India Aptamers Sales Value by Type (%), 2024 VS 2031
  • Figure 47. India Aptamers Sales Value by Application (%), 2024 VS 2031
  • Figure 48. Aptamers Industrial Chain
  • Figure 49. Aptamers Manufacturing Cost Structure
  • Figure 50. Channels of Distribution (Direct Sales, and Distribution)
  • Figure 51. Bottom-up and Top-down Approaches for This Report
  • Figure 52. Data Triangulation
  • Figure 53. Key Executives Interviewed